Skip to Main Content

Paper Details

Pharmacological Targeting of STK19 Inhibits Oncogenic NRAS-Driven Melanomagenesis.
Cell
57
2019
BRAF, NRAS, NRAS mutations, NRASQ61R, STK19, STK19D89N, ZT-12-037-01, human, melanocyte, melanoma, melanomas, oncogenic NRAS, serine, serine/threonine kinase, skin hyperpigmentation, threonine
Author NameAffiliation
Zhi WeiNew Jersey Institute of Technology
Colin R GodingLudwig Institute for Cancer Research, University of Oxford
  • 1 - 2

Datasets

Release 1.2